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Abstract
Background:  Wnt signaling is a key regulator of development and tumorigenesis. Protein
phosphatase 2A (PP2A), which consists of a catalytic C, a structural A, and a regulatory B subunit,
plays diverse roles in Wnt signaling through its B56 subunits. B56 is a multigene family encoding for
proteins with a conserved core domain and divergent amino- and carboxy-termini. Ectopic B56α
and B56γ reduce β-catenin abundance and B56α reduces Wnt-dependent transcription, suggesting
that B56α and B56γ inhibit Wnt signaling. In contrast, B56ε is required for Wnt signaling.
Knowledge of where and when B56 subunits are expressed during Xenopus development will aid
in our understanding of their roles in Wnt signaling.
Results: We have undertaken expression analyses of B56α and B56γ in Xenopus laevis. We cloned
Xenopus B56α; it is 88% identical to human B56α. Xenopus B56γ is 94% identical with human B56γ,
however, a novel evolutionarily conserved mixed-isoform transcript was identified that contains a
B56δ-like amino-terminal domain and a B56γ core domain. The B56δ-like variable domain exon is
located upstream of the B56γ variable domain exon at the human B56γ locus, suggesting that the
mixed-isoform transcript is due to alternative splicing. B56γ transcripts with different 3' ends were
identified that lack or possess a 35 base pair sequence, resulting in either a transcript similar to
human B56γ1, or an uncharacterized evolutionarily conserved sequence. Real time RT-PCR
analyses revealed that B56α is expressed at moderate levels before the midblastula transition
(MBT), at reduced levels during gastrulation and neurulation, and at high levels during
organogenesis, while B56γ is expressed at low levels until organogenesis. B56α is enriched in the
ventral hemisphere pre-MBT, while B56γ is ventrally enriched post-MBT. Aα, Aβ, Cα and Cβ are
expressed in early Xenopus development, suggesting the presence of a functional heterotrimer.
Conclusion:  Our data suggest that B56 functional diversity is achieved in part through the
synthesis of a novel mixed-isoform B56δ/γ transcript. Our data also suggest that B56α functions
pre-MBT, inhibiting Wnt signaling on the ventral side of the embryo, and again during
organogenesis, while B56γ functions primarily post-MBT.
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Background
Wnt ligands can activate canonical or planar cell polarity
Wnt pathways. In canonical signaling, Wnt activates β-cat-
enin-dependent transcription via a phosphorylation-regu-
lated signal transduction cascade. In the absence of Wnt,
casein kinase Iα (CKIα) primes β-catenin by phosphor-
ylating Ser45, which is required for glycogen synthase
kinase 3β (GSK3β) to phosphorylate three upstream Ser/
Thr residues [1,2]. GSK3β also phosphorylates adenoma-
tous polyposis coli (APC) and axin [3]. GSK3β, β-catenin,
APC, and axin comprise the core components of the β-cat-
enin degradation complex. APC and axin promote the
interaction of GSK3β with β-catenin, and therefore also
promote its phosphorylation [4]. Phosphorylated β-cat-
enin is ubiquitinated and degraded by the proteasome.
When Wnt binds to LRP5/6 and frizzled (fz) coreceptors,
an intracellular signaling cascade is activated that includes
axin binding to LRP5/6, and disheveled (dsh/dvl) phos-
phorylation and binding to fz [5-7]. These events lead to
destabilization of the β-catenin degradation complex,
reduced β-catenin phosphorylation, and increased β-cat-
enin abundance. β-catenin then forms a complex with a
Lef/Tcf transcription factor, activating transcription of
dorsalizing factors in early Xenopus development and cell
cycle regulators in mammalian cells [8-10].
Although phosphorylation cascades have been intensely
studied, relatively little is known about the role that phos-
phatases play in them. Phosphatase catalytic subunits are
bound to targeting and regulatory subunits in multimeric
complexes. PP2A is an abundantly expressed Ser/Thr
phosphatase that has roles in DNA replication, cell cycle
control, apoptosis, development, and tumorigenesis [11].
The inhibition of PP2A can cause cell proliferation and
aberrant development. The phosphatase inhibitor oka-
daic acid induces skin and gastrointestinal tract cancers,
and four mutations in a PP2A subunit, Aα, identified in
human tumors, have reduced PP2A function [12-14].
PP2A is comprised of a structural A, catalytic C, and regu-
latory B subunit. The B subunit confers substrate specifi-
city and subcellular localization on the PP2A holoenzyme
[15,16]. There are three distinct families of B subunits:
B55, B56, and PR72. There may be as many as sixty dis-
tinct PP2A holoenzymes, since the A and C subunits, as
well as each B subunit family, are encoded by multiple
genes. B56 is the largest family of B regulatory subunits
[15,17-20]. In humans, B56 is encoded by five highly
related and widely expressed genes (B56α, B56β, B56γ,
B56δ, and B56ε) that share a 71–88% identical 400
amino acid central core domain and highly variable
amino- and carboxy-terminal extensions. The B56 family
consists of two subfamilies based on amino acid similar-
ity, B56α/β/ε and B56δ/γ [15]. The three-dimensional
structure of a PP2A heterotrimer containing human B56γ1
has recently been determined [21]. B56γ1 forms eight
pseudo-HEAT repeats (named for the four founding pro-
teins: huntington, elongation factor 3, PP2A A, and
TOR1), each of which is comprised of two antiparallel α-
helices connected by intra-repeat loops. B56γ1 binds to
the A subunit through the "basal" surface of pseudo-HEAT
repeats 2, 4, and 6, and to the C subunit through its intra-
repeat loops. The B56 subunit is proposed to bring about
isoform specificity both through its amino- and carboxy-
termini and through the "apical" surface of its pseudo-
HEAT repeats [21].
B56α/β/ε subfamily members have roles in both canoni-
cal and planar cell polarity Wnt signaling. In many cases,
B56 is inhibitory to canonical Wnt signaling. B56α
reduces  β-catenin abundance and Wnt-dependent gene
expression in multiple experimental systems [22]. B56α's
ability to reduce β-catenin abundance depends on the
phosphatase activity of PP2A, since the inhibition of this
activity in mammalian cells results in increased β-catenin
abundance. Importantly, PP2A B56α, A, and C subunits
each reduce Xwnt-8-induced secondary axes, suggesting
that B56α increases B56α-specific PP2A activity rather
than reducing nonB56α activity by sequestration of the
PP2A AC heterodimer. In addition, B56α reduces the half-
life of β-catenin in an in vitro β-catenin degradation assay,
and the increased half-life of β-catenin in the absence of
PP1 and PP2A catalytic subunits is restored by the addi-
tion of the C subunit of PP2A, but not PP1 [23]. Epistasis
and coimmunoprecipitation data suggest that PP2A:B56α
is a component of the β-catenin degradation complex,
and that CKIδ/ε dissociates PP2A from the complex
[23,24]. In addition, ΔNp63, an oncogenic p53 paralog,
appears to activate Wnt signaling through its ability to
bind to B56α in the absence of other PP2A subunits, pre-
venting B56α from activating GSK3β [25]. Wdb, a B56α/
β/ε family member most closely related to B56ε, influ-
ences both canonical and planar cell polarity Wnt signal-
ing during Drosophila and zebrafish development. WdbIP,
a partial loss-of-function allele of wdb in Drosophila,
causes wing and eye outgrowths in a homozygous state,
indicative of excessive Wnt signaling, while morpholino
antisense oligonucleotides (MOs) against two zebrafish
wdb genes together induce planar cell polarity defects at a
low dose and dorsalization at a high dose [26]. In con-
trast,  Xenopus  B56ε activates canonical Wnt signaling,
functioning between Wnt and dsh/dvl to positively regu-
late Wnt signaling in dorsal development, midbrain-hind-
brain boundary formation, and neural tube closure [27].
There is growing evidence that B56γ functions as a tumor
suppressor. A B56γ deletion mutant is unable to dephos-
phorylate paxillin, and enhances cell spreading as well as
metastasis [28]. The small t DNA tumor virus antigen (sm
t) enhances cell growth through inhibition of B56-specificBMC Developmental Biology 2007, 7:139 http://www.biomedcentral.com/1471-213X/7/139
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PP2A activity [12,29-31]. In fact, the B56γ binding site of
sm t is required for sm t to activate Wnt signaling and
transform human papilloma virus-infected keratinocytes,
an in vivo model of cervical cancer progression [32]. In
mouse, the transgenic overexpression of B56γ in lung tis-
sue reduces β-catenin abundance and disrupts distal lung
differentiation, resulting in neonatal death [33]. To better
understand the distinct roles of the B56 family of PP2A
regulatory subunits in early Xenopus  development, we
cloned  Xenopus laevis B56α, analyzed B56α and B56γ
sequences, and undertook a quantitative analysis of the
expression of B56α, B56γ, and B56ε using real time RT-
PCR on RNA collected from Xenopus laevis embryos at sev-
eral points in development in both whole and hemisected
embryos. We found dynamic and dissimilar expression
patterns, reinforcing the hypothesis that B56α, B56γ, and
B56ε have distinct roles in development and in their abil-
ity to influence Wnt signaling.
Results
To facilitate our study of the role of B56 subunits during
Xenopus development, a full-length Xenopus B56α cDNA
was isolated from a Xenopus maternal cDNA library using
human B56α as a probe. B56α is highly conserved
between humans and Xenopus, the protein sequences are
88% identical and 92% similar overall. The proteins are
more conserved in the core domain (93% identity) than
in the amino- and carboxy-terminal variable domains
(66% and 46% identity, respectively) (Fig. 1A). This high
level of sequence conservation suggests the conservation
of B56α function between frog and humans.
We identified a Xenopus B56γ cDNA from sequence data-
bases that has 94% identity and 96% similarity to human
B56γ1. The core domain is highly related to human B56γ1
(98% identical), but the Xenopus and human genes are
divergent at their amino- and carboxy-termini (15% and
38% identity, respectively). When the amino-terminus
was examined more closely, we found that it had higher
identity to B56δ than to B56γ, and we termed this mixed-
isoform transcript B56δ/γ. Sequence databases were then
screened for additional Xenopus laevis B56γ sequences, and
a B56γ cDNA clone was found that had a B56γ-like amino-
terminus (B56γ/γ). To verify that B56δ/γ and B56γ/γ were
representative of actual mRNA transcripts and were not
cloning artifacts, RT-PCR was carried out with RNA from
stage 32 embryos with upstream primers specific for either
the Xenopus laevis B56δ or B56γ 5' variable domain, and a
downstream primer specific to the B56γ core domain. The
sequencing data obtained with the products from each of
these reactions concur with our initial findings and sug-
gest the presence of two B56γ transcripts in Xenopus laevis
with alternative 5' ends. The B56δ/γ mixed-isoform tran-
script encodes an 82 amino acid amino-terminal domain
that is 66% identical to human B56δ, while the B56γ/γ
transcript encodes a 19 amino acid domain that is 89%
identical to human B56γ (Fig. 2AB). In both cases, the
core domain is identical, and has 98% identity to human
B56γ, compared to 89% identity to the human B56δ core
domain. (Fig. 1B and data not shown). A search of
sequence databases identified seven species that possess
this novel mixed-isoform B56δ/γ transcript: Xenopus tropi-
calis, humans, chimpanzee, rhesus monkey, mouse, rat,
and zebrafish (Fig. 2C). Therefore, this novel B56δ/γ tran-
script is evolutionarily conserved.
To further study the origin of the mixed-isoform B56δ/γ
transcript, we examined the human genome database. The
human B56δ 5' variable domain upstream of the B56γ
core is distinct from the human B56δ 5' variable domain
upstream of the B56δ core, being 51% identical, and
therefore is termed B56δ-like (Fig. 3A). In fact, the human
B56δ and B56δ-like sequences are more highly related to
the Xenopus laevis sequence than each other, suggesting
that the B56δ and B56γ genes are the result of a duplica-
tion of the B56δ/γ gene. If the novel mixed-isoform B56δ/
γ transcript is the result of alternative splicing of the B56γ
gene, then the B56δ-like 5' variable domain should be
present on chromosome 14p32.2, where B56γ is located
[34]. Indeed, the B56δ-like 5' variable domain is present
on chromosome 14p32.2 in an exon upstream of the B56γ
5' variable domain exon (Fig. 3B). The B56δ/γ mixed-iso-
form transcript is thus a splice-variant from the B56γ
locus.
Our data, and that of others, has shown that Xenopus laevis
possesses B56α, B56γ (both B56δ/γ and B56γ/γ), and B56ε
orthologs. In addition, we found a partial cDNA of B56β
(XDB3.2 clone number rXL259o17ex) but we were una-
ble to find evidence of expression of a B56δ core domain.
Since the sequencing of the Xenopus tropicalis genome is
near completion, and because of the high level of related-
ness between Xenopus tropicalis and  Xenopus laevis, we
searched  Xenopus tropicalis sequences to determine its
complement of B56 genes, with the expectation that this
is likely to also represent the B56 complement in Xenopus
laevis. We used both Xenopus laevis and human B56 iso-
form sequences to screen sequence databases for Xenopus
tropicalis B56 genes. We found B56α, B56γ (both B56δ/γ
and B56γ/γ), B56ε, and B56β orthologs, but no isoform
with a B56δ core domain. B56β is expressed most highly
in adult brains [17,35], and the tropicalis  B56β was
sequenced from an adult brain cDNA library. Although
we did not find a laevis or tropicalis B56δ core domain,
Danio rerio does possess a B56δ sequence containing the
B56δ core domain (GI:40353001), suggesting either that
Xenopus has a B56δ core domain but it has not yet been
sequenced, or that Xenopus has lost this gene.BMC Developmental Biology 2007, 7:139 http://www.biomedcentral.com/1471-213X/7/139
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Alignment of Xenopus laevis and human B56α and B56γ proteins Figure 1
Alignment of Xenopus laevis and human B56α and B56γ proteins. Dark blue regions signify identity, light blue regions 
signify similarity, and dashes signify gaps. The amino-terminal variable domain is boxed in green, while the carboxyl-terminal 
variable domain is boxed in red. A. Sequences of Xenopus laevis (Xl) and human (Hs) B56α proteins are aligned. B. Sequences 
of Xenopus laevis (Xl) and human (Hs) B56γ proteins are aligned.
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Alignment of B56γ amino- and carboxy-terminal variable domains Figure 2
Alignment of B56γ amino- and carboxy-terminal variable domains. Sequence alignments are annotated as described 
in Figure 1. A. Alignment of Xenopus laevis B56δ/γ and human B56δ amino-terminal variable domains. B. Alignment of Xenopus 
laevis B56γ/γ and human B56γ amino-terminal variable domains. C. Alignment of Xenopus laevis (Xl), Xenopus tropicalis (Xt, 
GI:39645667), Pan troglodyte (Pt, GI:114654932), Macaca mulatta (Mm2, GI:109084945), human (Hs, GI:47077243), Mus mus-
culus (Mm1, GI:37359748), Rattus norvegicus (Rn, GI:109478743), and Danio rerio (Dn, GI:113674011) B56δ/γ sequences 
from the B56δ-like amino-terminal variable region through the first ten amino acids of the B56γ core domain. The division 
between the variable domain and the core domain is marked by an arrowhead. D. Alignment of an alternative long form of the 
B56γ carboxy-terminal variable domain with the species described in C; Xenopus tropicalis (GI:45361341), Mus musculus 
(GI:71153488), Rattus norvegicus (GI:109478743), Macaca mulatta (GI:109084945), human (GI:31083259), Danio rerio 
(GI:113674011), Pan troglodyte (GI:114607473).
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Alternative splicing occurs at the 3' end of human B56γ,
resulting in B56γ1, B56γ2, and B56γ3 transcripts [34]. We
found two alternative forms for the 3' end of the Xenopus
laevis  B56γ transcript. One isoform is most similar to
human B56γ1 (Fig. 1B). The second form has an insertion
of thirty-five nucleotides downstream of the core domain
that leads to a frame-shift. The resulting open reading
frame does not have significant identity to the 3' end of
human B56δ, B56γ1, B56γ2, or B56γ3. However, this
sequence is conserved in Xenopus tropicalis, humans, chim-
panzee, rhesus monkey, bovine, dog, bovine, rabbit,
mouse, rat, chicken, puffer fish, and zebrafish (Fig. 2D
and data not shown), and is expressed in mouse testis
[36]. Therefore, this alternative 3' end of the B56γ tran-
script is also evolutionarily conserved.
Knowledge of where and when B56α and B56γ are
expressed during Xenopus  development will aid in our
understanding of their role in Wnt signaling. To deter-
mine the expression pattern of B56α and B56γ, real-time
reverse transcriptase-polymerase chain reaction (RT-PCR)
was carried out on Xenopus embryos at several stages in
early development. The expression patterns of B56α and
B56γ were compared to that of B56ε, whose expression
pattern has previously been reported, so that even slight
differences in their expression patterns could be detected
[27].
Because B56 genes are members of a highly conserved
family, we first verified that the primer pairs that we
designed were isoform specific. We designed B56α, B56γ,
or B56ε primer pairs to amplify their 3' variable regions.
We also designed B56γ primer pairs to amplify either the
B56δ-like or B56γ 5' variable regions. The B56γ primer
pair at the 3' end of the gene amplified all of the B56γ
transcripts identified here: transcripts with either the
B56δ-like or B56γ 5' variable regions, as well as both the
short and long 3' alternative splicing products. Real-time
PCR was then performed with each B56 primer pair and
B56α, B56γ, or B56ε plasmid templates. Each primer pair
specifically amplified only the corresponding isoform
(Fig. 4E). These isoform-specific primer pairs were then
used to examine the expression pattern of B56α, B56γ,
and B56ε in early Xenopus development. B56α is expressed
at approximately 45% of the stage 32 value prior to MBT
(egg – stage 7), at approximately 10% of the stage 32 value
during gastrula and neurula stages (stages 10 – 19), and its
expression gradually increased to its highest expression
level during organogenesis (stages 23–32) (Fig. 4A). The
expression level of all of the B56γ transcripts described
here was highest at stage 32 (Fig. 4C). B56γ expression was
approximately 25% of the stage 32 value from the egg to
neurula stages (egg to stage 19), and increased during org-
anogenesis. The B56δ/γ transcript was expressed at mod-
erate levels until organogenesis, while B56γ/γ was not
significantly expressed until neurulation, while B56δ/γ
and B56γ/γ both displayed increased expression during
organogenesis (Fig. 4D). The expression level of B56ε was
relatively unchanged from the egg to stage 32 (Fig. 4B).
This data suggests that B56α has at least two functions
during early Xenopus development, one during cleavage
stages and another during organogenesis. In contrast,
B56γ/γ appears to have its primary function during orga-
nogenesis, while B56δ/γ may function throughout early
development.
If B56 subunits function as regulatory subunits of PP2A
heterotrimers during Xenopus development as we hypoth-
The B56δ-like amino-terminal variable domain is distinct from B56δ and encoded at the B56γ locus Figure 3
The B56δ-like amino-terminal variable domain is distinct from B56δ and encoded at the B56γ locus. A. Human 
B56δ and human B56δ-like amino-terminal variable domains are 51% identical. Sequence alignments are annotated as described 
in Figure 1. B. The exon encoding the B56δ-like amino-terminal variable domain (Exon 1a, light blue and dark blue bars repre-
sent noncoding and coding sequences, respectively) is upstream of the exon encoding the B56γ amino-terminal variable domain 
(Exon 1b, light green and dark green bars represent noncoding and coding sequences, respectively) in the human B56γ gene 
(chromosome 14p32.2). The introns are represented by lines and are shown in scale with one another, but not in scale with 
the exons.
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B56α and B56γ are differentially expressed during early Xenopus development Figure 4
B56α and B56γ are differentially expressed during early Xenopus development. RNA was purified from Xenopus lae-
vis embryos at the indicated stages, and real time RT-PCR was carried out. A standard curve was done from stage 32 embryos, 
and signals were normalized to that stage. A. B56α is expressed at approximately 45% of the stage 32 value prior to MBT, at 
approximately 10% of the stage 32 value during gastrula and neurula stages, and its expression gradually increases to its highest 
expression level during organogenesis. B. The expression level of B56ε is relatively unchanged from the egg to stage 32. C. The 
expression level of B56γ is highest during organogenesis and is approximately 25% of that value during earlier stages (unferti-
lized egg to stage 19). D. The mixed-isoform B56δ/γ transcript is expressed at moderate levels until organogenesis (dark blue 
bars), while B56γ/γ is not significantly expressed until neurulation (light blue bars); both B56δ/γ and B56γ/γ display increased 
expression during organogenesis. E. A dose response curve of real time RT-PCR amplification data shows that B56α, B56γ, and 
B56ε primer pairs are isoform specific. Input plasmid DNA concentrations are plotted against their concentration calculated 
from the amplification of the correct primer pair/template combination.
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esize, then the A and C subunits should be concurrently
expressed. Vertebrates possess two A isoforms, Aα and Aβ,
as well as two C isoforms, Cα and Cβ. We carried out real
time RT-PCR to examine the expression patterns of Aα,
Aβ, Cα, and Cβ during early Xenopus laevis development.
Because the A and C isoforms are highly conserved (the
coding regions of Aα and Aβ are 73% identical, and Cα
and Cβ are 79% identical), we first performed real-time
PCR with Aα, Aβ, Cα, and Cβ primer pairs and Aα, Aβ,
Cα, or Cβ plasmid templates to verify the isoform specifi-
city of our primer pairs. Each primer pair specifically
amplified only the corresponding isoform (Fig. 5E). These
PP2A Aα, Aβ, Cα, and Cβ are differentially expressed during early Xenopus development Figure 5
PP2A Aα, Aβ, Cα, and Cβ are differentially expressed during early Xenopus development. RNA was purified from 
Xenopus laevis embryos at the indicated stages, and real time RT-PCR was carried out. A standard curve was done from stage 
32 embryos, and signals were normalized to that stage. A. Aα is expressed at low levels until organogenesis. Aβ (B) and Cα 
(C) are expressed at moderate levels through gastrulation, and at progressively increasing levels during neurulation and orga-
nogenesis. D. Cβ is expressed at similar levels from the egg to stage 32, with the exception of its reduced expression during 
neurulation. E. A dose response curve of real time RT-PCR amplification data shows that Aα, Aβ, Cα, and Cβ primer pairs are 
isoform specific. Input plasmid DNA concentrations are plotted against their concentration calculated from the amplification of 
the correct primer pair/template combination.
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isoform-specific primer pairs were then used to examine
the expression pattern of Aα, Aβ, Cα, and Cβ in early Xeno-
pus development. Aα was expressed at low levels until org-
anogenesis, whereas Aβ and Cα were expressed at
moderate levels from the egg through gastrulation, and at
progressively increasing levels during neurulation and
organogenesis (Fig. 5A–C). Cβ was expressed at similar
levels from the egg to stage 32, with the exception of its
reduced expression during neurulation (Fig. 5D). There-
fore, each of the components of the PP2A heterotrimer is
present during early Xenopus development, suggesting that
competent PP2A heterotrimers containing B56α, B56γ,
and B56ε are present during early Xenopus development.
To further explore the expression pattern of PP2A subu-
nits during Xenopus  development, we localized their
expression by real-time RT-PCR analyses of hemisected
embryos. In general, RNA is more abundant in the animal
hemisphere of the early Xenopus  embryo because yolk
plasm in the vegetal hemisphere reduces cytoplasmic vol-
ume. Total RNA, as well as poly(A)+ RNA, is two to four
fold more abundant animally versus vegetally [37,38].
This differential distribution of RNA continues into gas-
trula stage embryos [37]. However, a number of maternal
RNAs are differentially localized beyond, or contrary to,
this inclination on the animal/vegetal axis. RNAs that will
become germ plasm constituents or RNAs required for
proper cell fate decisions, such as Vg1, are enriched vege-
tally [39]. Other RNAs, such as Tcf-1 and β-TrCP, are
enriched animally [39]. We analyzed the expression of
PP2A subunits in animal/vegetal hemisected embryos.
B56α, B56γ, B56ε, Aα, Aβ, Cα, and Cβ were animally
enriched approximately 4-fold at stage 7 and 1.5-fold at
stage 10 (Fig. 6A–D, F–I). Ornithine decarboxylase
(ODC), a housekeeping gene, had a similar distribution,
whereas Vg1, a dissection marker, was vegetally enriched
approximately nine-fold at each of these stages (Fig.
6D,E). Therefore, the PP2A subunits that we examined,
like most maternal RNAs, are enriched in the animal hem-
isphere.
RNA is not equally distributed dorsoventrally in Xenopus
embryos. Total RNA is much higher in the dorsalmost
region of the embryo at stage 3, while poly(A)+ RNA is
equally distributed in the ventral and dorsal halves, caus-
ing a higher poly(A)+ to total RNA ratio on the ventral
side of the embryo [37]. Several RNAs display differential
dorsal/ventral localization during early Xenopus develop-
ment [40]. In stage 5 embryos, for example, EF1α, goose-
coid, and noggin are enriched on the dorsal side of the
embryo, while Wnt8b is ventrally enriched, where it is
required to inhibit dorsal cell fate [40]. Since B56 subunits
influence dorsoventral body axis formation, we deter-
mined if there are any dorsoventral differences in their
expression [23,27,33]. We carried out real-time RT-PCR
on ventral/dorsal hemisected embryos at stages 3, 7, and
10 to determine if B56α or B56γ are differentially local-
ized during dorsoventral axis specification, as well as to
localize Aα/β and Cα/β expression. We found that most of
the examined PP2A subunits were relatively equally dis-
tributed dorsoventrally, or were slightly higher dorsally.
However, B56α at stage 3 and B56γ at stage 10 are an
exception to this pattern, since they are more abundant
ventrally (Fig. 7). Dissection markers Vg1 (stage 3) and
Xnr6 (stages 7 and 10) were 2.5 – 4 fold higher dorsally,
as expected (Fig. 7D, [41,42]). These expression patterns
suggest that B56α may be inhibiting Wnt activity on the
ventral side of the embryo in the initial stages of dorsal
axis specification, whereas B56γ may carry out this func-
tion post-MBT. However, the magnitude of the differen-
tial localizations of B56α and B56γ is not large, and
posttranscriptional mechanisms may also play a role in
the spatial regulation of PP2A:B56 heterotrimers in the
early embryo.
Discussion
Humans possess five B56 family members: B56α, B56β,
B56γ, B56δ, and B56ε. We isolated the Xenopus laevis B56α
gene and characterized B56γ transcripts present during
early Xenopus laevis development. We also found a partial
B56β cDNA; B56ε has previously been isolated [43]. The
B56δ core domain has not been found in Xenopus laevis
cDNA library sequences from public databases, suggesting
that it is not present in early stage embryos. The B56δ core
domain is highly expressed in the brain [35,44], and is
present in Danio rerio, but has not yet been sequenced in
laevis or tropicalis, suggesting that the appropriate adult
library may not have been sequenced, or that Xenopus has
lost the B56δ gene.
B56 proteins are comprised of a conserved central core
domain and divergent amino- and carboxy-terminal
extensions. The core interacts with the highly conserved A
and C subunits, while the variable domains provide sub-
strate specificity by binding diverse substrates. B56α and
B56γ core domains are highly conserved between humans
and  Xenopus, while the amino- and carboxy-terminal
extensions are less well conserved. In fact, each residue in
human B56α and B56γ that interacts directly with the A
and C subunits [21] is identical in Xenopus laevis. The rel-
ative conservation of the core domains and divergence of
the amino- and carboxy-terminal variable domains of
B56α and B56γ between humans and Xenopus is likely to
reflect their interactions with disparate types of protein
binding partners: the core interacting with A and C subu-
nits, and the amino- and carboxy-terminal domains inter-
acting with substrates, proteins that are not likely to be as
highly conserved as the A and C subunits.BMC Developmental Biology 2007, 7:139 http://www.biomedcentral.com/1471-213X/7/139
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Our data suggest that diversity of B56 function is achieved
in part through the synthesis of alternative transcripts that
result in distinct amino- and carboxy-terminal domains.
We identified a novel mixed-isoform B56δ/γ transcript in
Xenopus laevis comprised of a B56δ-like amino-terminal
variable domain and a B56γ core domain, as well as a
B56γ transcript possessing an alternative 3' end. Each of
these variants is evolutionarily conserved, and is present
in humans. The intense conservation of these novel B56γ
transcripts suggest that they are functional, because if they
were not functional, their sequence would rapidly drift
away from the consensus. The identification of a mixed-
isoform B56δ/γ transcript suggests that alternative splicing
leads to a "fine-tuning" of PP2A substrate specificity.
The expression of several B subunits during Xenopus devel-
opment has been examined. Northern blotting analyses
show that the B55 subunit is present at constant levels
from the egg to metamorphosis, and present in the adult
in the ovary, testis, muscle, and liver [45]. The expression
of multiple PR72 isoforms was examined in Xenopus
oocytes and adult tissues by hybridization detection of
RT-PCR products [46]. XPR130 is expressed at low levels
in the oocyte and at higher levels in the liver, gall bladder,
spleen, heart, and muscle, while XPR70 is expressed at
high levels in oocytes and each of the tissues mentioned
above. B56ε, which is required for Wnt signaling, is
expressed maternally and throughout early Xenopus devel-
opment [27]. Its expression is uniform in the embryo
until MBT, when its expression, as determined by in situ
PP2A subunits are enriched in the animal hemisphere of Xenopus embryos Figure 6
PP2A subunits are enriched in the animal hemisphere of Xenopus embryos. Xenopus laevis embryos at stages 7 and 
10 were hemisected into animal and vegetal halves. RNA was purified from the hemisected halves and real time RT-PCR was 
carried out. The data is presented as the percentage of the total signal that is present in the specified hemisphere ± SD. B56α 
(A), B56γ (B), B56ε (C), Aα (F), Aβ (G), Cα (H), and Cβ (I) are enriched in the animal hemisphere of stage 7 and 10 Xenopus 
embryos. Dissection control ODC (D) is enriched animally, while Vg1 (E) is enriched vegetally. A = animal, V = vegetal.
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hybridization, becomes localized to the dorsal marginal
zone in early gastrulation and expands to the entire mar-
ginal zone during midgastrulation. B56ε is expressed in
the neural ectoderm during neurulation and in the eyes
and branchial arches in the tadpole. We demonstrate here
that B56α and B56γ, both of which have Wnt-inhibitory
activities, display dynamic expression patterns in early
Xenopus development. B56α is expressed at moderate lev-
els before MBT, when it may inhibit Wnt pathway activity
on the ventral side of the embryo, at reduced levels during
gastrulation and neurulation, and at high levels during
organogenesis, while B56γ is expressed at moderate levels
until organogenesis. B56γ has been shown to have a cru-
cial role during lung development in the mouse, which is
consistent with our finding that it is highly expressed dur-
ing organogenesis [33].
Prior to this report, Aβ and Cα were known to be
expressed in Xenopus embryos, however, we detected Aα,
Aβ, Cα, and Cβ expression during early Xenopus develop-
ment. PP2A A and C subunit expression has previously
been examined by Northern and western blotting. PP2A
Cα and Cβ were both undetectable until stage 35 by
Northern blotting, when Cα is expressed at higher levels
than Cβ; in adults, they are most abundant in the ovary
and heart [47]. However, a more recent report using
Northern blotting shows that Cα is expressed at similar
levels from the egg through the gastrula stage [48]. Our
results concur with these findings, but show that both Cα
and Cβ RNAs are present in the egg and throughout early
development. Cα and Cβ expression increases during org-
anogenesis, when Van Hoof et al. first detected expression
([47], Fig. 5C–D). The expression of PP2A Aα and Aβ iso-
forms in Xenopus has previously been studied by western
blotting, where it was found that Aβ is expressed in the
oocyte and both Aα and Aβ are expressed in skeletal mus-
cle [49], and by Northern blotting, where it was found
that Aβ is expressed at similar levels from the oocyte to
metamorphosis, whereas Aα expression is undetectable
until stage 35 [45]. In adults, Aβ is highly expressed in the
The dorsoventral distribution of PP2A subunits in Xenopus embryos Figure 7
The dorsoventral distribution of PP2A subunits in Xenopus embryos. Xenopus laevis embryos at stages 3, 7, and 10 
were hemisected into dorsal and ventral halves. RNA was purified from the hemisected halves and real time RT-PCR was car-
ried out. The data were normalized to ODC expression levels, and are presented as the percentage of the total signal present 
in the specified hemisphere. PP2A A and C subunits Aα (E), Aβ (F), Cα (G), and Cβ (H) are relatively equally distributed dors-
oventrally or slightly enriched dorsally. However, B56α (A) at stage 3 and B56γ (B) at stage 10 are more abundant ventrally. 
Dissection controls Vg1 (stage 3) and Xnr6 (stages 7 and 10) are enriched dorsally (D). D = dorsal, V = ventral.
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ovary, but expressed at reduced levels in all other tissues
examined, while Aα is highly expressed in muscle, heart,
and testes, and moderately expressed in liver, lung, and
spleen [45]. Our results concur with these findings, but
presumably due to the increased sensitivity of real-time
RT-PCR as compared to Northern blotting, Aα was found
to be expressed at low levels prior to organogenesis, after
which its expression sharply increased, while expression
was relatively more constant for Aβ (Fig. 5A–B). Since
PP2A functions as a heterotrimer, the presence of Aα/β
and Cα/β isoforms in early Xenopus development suggests
that B56α and B56γ, as well as any other B subunits
expressed during this time, will associate with A and C
subunits, forming a functional heterotrimer.
The enrichment of B56α RNA on the ventral side of a 4
cell-stage embryo, against the trend of the A and C subu-
nits to be enriched dorsally or equally distributed, sug-
gests that B56α's ventral enrichment is significant. This,
along with our previous data showing that B56α can
inhibit Wnt signaling [22,23], suggest that B56α is func-
tioning pre-MBT in ventral cells to inhibit dorsal cell fate.
Other pre-MBT dorsoventral asymmetries exemplified by
ventral enrichment have been identified. Wnt8b is
enriched ventrally at the 16 cell-stage, where it represses
dorsal cell fate [40]. Dorsal-specific signaling does occur
pre-MBT, since Wnt-dependent transcription of Xnr5 and
Xnr6 is detected as early as the 256 cell-stage [42]. The
enrichment of B56γ RNA on the ventral side of the
embryo at stage 10, again against the trend of the A and C
subunits to be enriched dorsally or equally distributed,
suggests that this enrichment is significant. B56γ can
reduce  β-catenin abundance [33], therefore its ventral
enrichment suggests that B56γ functions post-MBT to
inhibit Wnt signaling. Further tests will be required to
determine if there is a requirement for ventral enrichment
of B56α and B56γ in specifying dorsoventral cell fate, such
as antisense morpholino oligonucleotide microinjec-
tions, which are currently underway.
Distinct PP2A heterotrimers may act on different sub-
strates, or at multiple sites within a given substrate, with
opposing consequences. Wnt signaling is regulated by
phosphorylation at multiple points. Numerous kinases
influence Wnt signaling, and each phosphorylation step
carried out by a kinase is likely to have a counterregulatory
dephosphorylation step carried out by a phosphatase.
Consequently, there are likely to be as many phosphatases
acting in the pathway as kinases. In contrast to the pleth-
ora of kinases, there are a limited number of phosphatase
catalytic subunits. Diversity of phosphatase function is
achieved through variation in the bound regulatory subu-
nit. Since PP2A is one of the most abundant phos-
phatases, it is reasonable to expect that PP2A has multiple
roles in the pathway. Evidence from our lab and others
suggest that this is the case even within the B56 family
[23,27,33,43,50].
The PR72 family plays an important role in Wnt signaling.
PR72 inhibits Wnt signaling through its interaction with
Nkd, another Wnt inhibitor, and promotes dsh degrada-
tion [51]. Another PR72 family member, PR130, also
binds to Nkd [52]. The binding of PR130 and PR72 to
Nkd may be mutually exclusive, with PR72 inhibiting Wnt
signaling when bound to Nkd due to its promotion of dsh
degradation, and PR130 activating Wnt signaling when
bound to Nkd by preventing Nkd-mediated Wnt inhibi-
tion. There are other gene families important to Wnt sign-
aling in which different members of the gene family affect
the pathway differently. For instance, CKIα inhibits the
pathway by promoting β-catenin degradation through the
phosphorylation of β-catenin's Ser45, while CKIδ/ε acti-
vates the pathway, possibly by destabilizing the β-catenin
degradation complex [1,2,24]. Therefore, the regulation
of Wnt signaling is clearly complex and cannot be com-
pletely understood until the roles of multigene families
that influence it have been characterized.
The expression of B56α and B56γ in early Xenopus laevis
development suggests that their regulation of PP2A activ-
ity at this time may influence Wnt signaling. It is of inter-
est to note that PP2A A subunit mutations have been
identified in human melanomas and colon, breast, and
lung tumors [13,53-57]. Interestingly, two PP2A Aα
mutant proteins initially identified in human cancers
bind every PP2A subunit at near wild-type levels except
B56 [13,14]. This suggests that the loss of B56-specific
PP2A activity is involved in tumorigenesis, and since
B56α and B56γ can inhibit Wnt signaling, this suggests
that the regulation of Wnt signaling by PP2A may be a crit-
ical factor in tumorigenesis. Future studies include the
localization of B56α and B56γ in early Xenopus develop-
ment through in situ hybridization, which will enhance
our knowledge of the spatiotemporal expression patterns
of B56α and B56γ, and B56α and B56γ loss-of-function
assays, each of which will help us understand in more
detail how B56α and B56γ influence Wnt signaling.
Conclusion
The activity of PP2A is regulated by the bound B subunit.
The B56 family of B subunits has five genes in mammals,
and our data suggest that diversity of B56 function is
obtained in part through alternative splicing of the 5' and
3' variable domains. We found that the B56γ transcript
can be comprised of either a B56δ-like or B56γ 5' variable
domain, and either a B56γ1-like or a novel conserved
sequence for its 3' variable domain. Our data also suggest
that B56α functions preMBT, inhibiting Wnt signaling on
the ventral side of the embryo, and again during organo-BMC Developmental Biology 2007, 7:139 http://www.biomedcentral.com/1471-213X/7/139
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genesis, while B56γ functions primarily during organo-
genesis.
Methods
Library screening and plasmids
Xenopus laevis maternal cDNA library in pBluescript SK+
(A. Zorn) was screened with digoxygenin-labeled human
B56α synthesized by PCR, and detected with DIG Lumi-
nescent Detection Kit (Roche, Indianapolis, IN). Positive
clones were sequenced by primer walking (Macrogen,
Seoul, Korea). Full length Xenopus laevis B56γ and B56ε
genes cloned in pSPORT6 were obtained from the Xenopus
Gene Collection in the I.M.A.G.E. consortium through
American Type Culture Collection (ATCC); GenBank
accession number of B56α: EU307104, B56γ: BC081028,
B56ε: BC084241.
RT-PCR and sequence analysis of B56γ transcripts
RT-PCR was performed with cDNA from stage 32 embryos
with the primers XlB56γ2U 5'-CCT CTT TTC CGG CAG
CTA G-3' and XlB56γ2D 5'-TTC CAT TGC AAC AGG ACT-
3'. PCR products were sequenced (Macrogen, Seoul,
Korea). Sequence analysis was performed with ClustalW
[62] and The Sequence Manipulation Suite [63].
Real-time RT-PCR
To verify the isoform specificity of the B56α, B56γ, B56ε,
Aα, Aβ, Cα, and Cβ primer pairs, real-time PCR was per-
formed using plasmid templates. Plasmid concentrations
of each family member were used (0.5 to 5 pg/μl, except
B56γ (3'end): 0.5 – 2.5 pg/μl) that exceed the signals
obtained with the cDNA samples as determined by their
Cp values. A 20 μl reaction included 1.8 to 3 μM primers,
10 μl of 2× SYBR master mix, 2 μl of template, and 0.5
units of Uracil-DNA glycosylase (New England Biolabs,
Beverly, MA). Real-time RT-PCR was done using Quant-
iTech SYBR green PCR kit (Qiagen, Valencia, CA) in the
LightCycler 2.0 (Roche, Indianapolis, IN). The reaction
program consisted of four steps: pre-incubation, quantita-
tion, melting curve analysis, and cooling. Data analysis
was performed by LightCycler 4.0 software (Roche, Indi-
anapolis, IN). The data were plotted using the standard
curve obtained using the correct DNA/primer pair combi-
nation.
Embryos were collected at different stages of development
[58]. Total RNA was extracted from embryos using Trizol
solution and a chloroform, isopropanol-tRNA solution.
RNA was washed with 70% ethanol and resuspended in
125 μl of DEPC-treated water per 10 embryos. cDNA syn-
thesis was done using 1 μg of total RNA with SuperScript
III First-Strand Synthesis SuperMix and random hexamers
(Invitrogen, Carlsbad, CA) following manufacturer's
instructions. For stage-specific expression, a dilution
series of stage 32 cDNA was used to generate a standard
curve to determine relative cDNA concentrations and sig-
nals were normalized to stage 32; error bars represent +/-
one standard deviation.
The following primers were used: XlB56α (U: 5'-TCA TAC
AAA GCA GAG CGA-3', D: 5'-TTC TGC ACA CAG AGA
GTA GG-3'), XlB56γ (U: 5'-TGC AGC TAA GAT TTT GCC-
3', D: 5'-TTC CAT TGC AAC AGG ACT-3'), XlB56δ/γ (U:
5'-ACT CCA CAG GCT GTT GTT-3', D: 5'-CAG GTC ACT
TAG AGG ATC AGA-3'), XlB56γ/γ (U: 5'-ATG GTG GTA
GAT GCA GCT AA-3', D: 5'-CAG GTC ACT TAG AGG ATC
AGA-3'), XlB56ε (U: 5'-ATT CAA ACG TCG TCC TTC-3',
D: 5'-CCA TCA CTC CTA AGA CCT CTC-3'), XPR65α (U:
5'-GGG GAC CTT TAC TTC ATT G-3', D: 5'-CTC ATG AGA
AAT GGC ACG-3'), XPR65β (U: 5'-GGG AAG CTT CAC
CAG TCT T-3', D: 5'-TTC CTC AAG GAG TCC ACT G-3'),
XC36α (U: 5'-GAG GGC CAG GTC AAG AGT-3', D: 5'-
TCA TGA TTT CCT CGG AGG-3'), XC36β (U: 5'-GGA AAC
CAG GCA GCT ATT-3', D: 5'-AAG GCA TCG TGT AAA
GAT TG-3'), Vg1 (U: 5'-CCA TAC CCG CTG ACA GAA AT-
3', D: 5'-CCT GCA GCC ACA CTC ATC TA-3') [59], Xnr6
(U: 5'-AAG ATT GGA TGG GGT CAT CA-3', D: 5'-ATC
AGC ATG GAC AAG GGA CT-3') [60], ODC (U: 5'-GCC
ATT GTG AAG ACT CTC TCC ATT C-3', D: 5'-TTC GGG
TGA TTC CTT GCC AC-3') [61].
Embryo dissections
Embryos were hemisected at stages 3, 7, and 10. The
planes of hemisection were determined based on pigmen-
tation differences for all animal/vegetal hemisections, as
well as stage 3 dorsal/ventral hemisections. Stage 7 dorsal/
ventral hemisection were done using embryos marked
with Nile blue at stage 3, and stage 10 dorsal/ventral
hemisections were done based on the location of the dor-
sal blastopore lip. Real-time RT-PCR was carried out on
hemisected halves of embryos as described above using
equal amounts of total RNA. Vg1 was used as a vegetal
marker, as well as a dorsal marker for stage 3, while Xnr6
was used as a dorsal marker for stages 7 and 10 [41,42]. In
each dissection, standard curves were generated using the
dissected half with the higher expression level. For dorsov-
entral-specific expression, signals were normalized to
ODC expression, while animal/vegetal dissection signals
are presented directly.
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